The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Laliberte Kevin since year 2005.
The trader's CIK number is 1709417.
At the time of the last reporting, Laliberte Kevin was the Sr. VP, Product Development of Dova Pharmaceuticals Inc. .
(stock ticker symbol DOVA).
See this page for all insider trading activities at Dova Pharmaceuticals Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-09-30||DOVA||Dova Pharmaceuticals Inc.||Sale||3,696||28.00||103,488|
|2019-09-25||DOVA||Dova Pharmaceuticals Inc.||Sale||3,100||20.00||62,000|
|2019-07-31||DOVA||Dova Pharmaceuticals Inc.||Sale||1,389||15.97||22,182|
|2019-07-01||DOVA||Dova Pharmaceuticals Inc.||Sale||1,191||14.17||16,876|
|2017-07-05||DOVA||Dova Pharmaceuticals Inc.||Buy||6,200||17.00||105,400|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Laliberte Kevin (Sr. VP, Product Development of Dova Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.